RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company, announced that the European Commission (EC) recently granted approval of ZTALMY® (ganaxolone) oral suspension for the adjunctive treatment of epileptic …